600196 復星醫藥
按盤價 
26.240 -1.050 (-3.848%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 30,911,889 | 0.69% | 41,399,540 | 43,951,547 | 39,011,184 | 30,306,981 | |
| 減：營業總成本 | 29,362,813 | -3.04% | 41,284,077 | 41,346,264 | 37,093,266 | 28,594,719 | |
| 其中:營業成本 | 15,889,600 | 0.70% | 21,595,309 | 23,169,690 | 20,229,785 | 13,733,529 | |
| 財務費用 | 854,565 | 13.03% | 984,323 | 647,403 | 464,022 | 724,273 | |
| 資產減值損失 | (40,947) | -85.92% | (219,742) | (272,488) | (829,873) | (148,254) | |
| 公允價值變動收益 | (106,246) | -113.18% | (427,380) | (2,498,368) | 352,299 | 578,657 | |
| 投資收益 | 1,498,763 | -31.33% | 3,501,993 | 4,377,843 | 4,623,826 | 2,283,981 | |
| 其中：對聯營企業和合營企業的投資收益 | 1,214,652 | -18.80% | 2,184,849 | 1,835,146 | 1,789,137 | 1,580,335 | |
| 營業利潤 | 3,107,589 | -7.02% | 3,307,508 | 4,656,656 | 6,302,568 | 4,721,145 | |
| 利潤總額 | 3,071,566 | -6.71% | 3,264,568 | 4,574,382 | 6,042,671 | 4,677,844 | |
| 減：所得稅費用 | 553,048 | -13.40% | 369,504 | 626,917 | 1,066,401 | 737,865 | |
| 淨利潤 | 2,518,518 | -5.10% | 2,895,063 | 3,947,464 | 4,976,269 | 3,939,980 | |
| 減：非控股權益 | 507,875 | 36.99% | 508,798 | 216,660 | 247,559 | 277,167 | |
| 股東淨利潤 | 2,010,642 | -11.93% | 2,386,266 | 3,730,805 | 4,728,711 | 3,662,813 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.750 | -12.79% | 0.890 | 1.430 | 1.850 | 1.430 | |
| 每股派息 (元) * | -- | -- | 0.270 | 0.420 | 0.560 | 0.430 | |
| 每股淨資產 (元) * | 17.700 | 3.01% | 17.110 | 16.684 | 15.292 | 14.435 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 22/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
